Tamoxifen modulates apoptotic pathways in primary endometrial cell cultures

Clinical Cancer Research

Volumn 7, Issue 2, 2001, Pages 415-420

  Stackievicz, R ^a   Drucker, L ^a   Radnay, J ^a   Beyth, Y ^a   Yarkoni, S ^a   Cohen, I ^a  

^a MEIR MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTRADIOL; ESTROGEN RECEPTOR; PROTEIN BCL 2; STEROID HORMONE; TAMOXIFEN;

ADULT; APOPTOSIS; ARTICLE; BREAST CANCER; CELL CYCLE G1 PHASE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; ENDOMETRIUM CARCINOMA; ENDOMETRIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; CELL LINE; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ESTRADIOL; FEMALE; HUMANS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0035127479     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Basic guide to the mechanisms of antiestrogens
2. Systemic treatment of early breast cancer by hormonal cytotoxic or immune therapy
3. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-I Study
4. The role of ultrasound in the detection of endometrial pathologies in asymptomatic postmenopausal breast cancer patients with tamoxifen treatment
5. Comparison of endometrial changes among symptomatic tamoxifen-treated and non-treated premenopausal and postmenopausal breast cancer patients
6. Tamoxifen for breast cancer: Associated endometrial cancer
7. Induction of apoptosis by tamoxifen and ICI 182.780 in primary breast cancer
8. Role of proliferation and apoptosis in net growth rate of human breast cancer cells (MCF-7) treated with oestrogen and/or tamoxifen
9. Effective tamoxifen therapy of breast cancer involves antiproliferative and pro-apoptotic changes
10. L without alteration of p53 protein levels
11. Influence of estrogen, antiestrogen and UV-light on the balance between proliferation and apoptosis in MCF-7 adenocarcinoma cells culture
12. What do we know and what don't we know about tamoxifen in the human uterus
13. Apoptosis in the pathogenesis and treatment of the diseases
14. The Hallmarks of Cancer
15. Apoptosis and cancer
16. Apoptosis in the endometrium
17. Apoptosis: Abasic biological phenomenon with wide-ranging implications in tissue kinetics
18. The effect of tamoxifen on endometrial hyperplasia
19. Stimulatory effects of 4-hydroxytamoxifen on proliferation of human endometrial adenocarcinoma cells (Ishikawa line)
20. 4-Hydroxytamoxifen binds to estrogen receptors and inhibits the growth of human endometrial cells in vitro
21. Expression of steroid receptors, Ki-67, and epidermal growth factor receptor in tamoxifen-treated endometrium
22. Endometrial hyperplasia in an oophorectomized woman receiving tamoxifen therapy. Case report
23. Selective estrogen receptor modulators. A look ahead
24. Bcl-2 expression and the development of endometrial carcinoma
25. Bcl-2 is down regulated in atypical endometrial hyperplasia and adenocarcinoma
26. Bcl-2 expression and prognosis of patients with endometrial carcinoma
27. Bcl-2 and Fas expression in eutopic and ectopic human endometrium during the menstrual cycle in relation to endometrial cell apoptosis
28. Cyclic bcl-2 gene expression in human uterine endometrium during menstrual cycle
29. Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium
30. Bcl-2 and the regulation of programmed cell death
31. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax
32. Estrogen-like effects of tamoxifen on human endometrial carcinoma transplanted into nude mice
33. Tamoxifen increases plasma estrogen-binding equivalents and has an estradiol agonistic effect on histologically normal premenopausal and postmenopausal endometrium
34. Tamoxifen induced proto-oncogene expression persists in uterine endometrial epithelium
35. Modulation of endometrial steroid receptors and grow regulatory genes by tamoxifen
36. Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7
37. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation